# FDA Inspection 1227303 - Sam E. Moussa, M.D. - November 17, 2023

Source: https://www.keypedia.com/records/fda_inspections/sam-e-moussa-md/d4bd5897-9514-4d29-89ae-009f47517edf
Source feed: FDA_Inspections

> FDA Inspection 1227303 for Sam E. Moussa, M.D. on November 17, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1227303
- Company Name: Sam E. Moussa, M.D.
- Inspection Date: 2023-11-17
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1111826 - 2019-11-21](https://www.keypedia.com/records/fda_inspections/sam-e-moussa-md/a821b23d-42ee-475b-af27-4e534aed9986)

Company: https://www.keypedia.com/companies/sam-e-moussa-md/f139dee4-f9cd-4e22-93db-13f93ea81048

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c